Covidien plc
News and overview for Covidien plc
Covidien quarterly net income drops 86% - MarketWatch
MarketWatch | 7 days 22 hours 59 minutes ago
COV
Covidien Reports Fourth-Quarter and Fiscal 2009 Results [Press Release]
Business Wire | 7 days 23 hours 26 minutes ago
Covidien plc (NYSE: COV) today reported results for the fourth quarter of fiscal 2009 (July – September 2009). Fourth-quarter net sales of $2.7 billion were essentially unchanged from those of a year ago, with unfavorable foreign exchange of $54 million reducing the quarterly sales growth rate by approximately 2 percentage points. The fourth-quarter results included several one-time items as shown in the attached quarterly Non-GAAP Reconciliations table, including income tax, legal and enviro...
Covidien says FDA extends review on pain drug Exalgo to Feb. 22
Hartford Courant (Conn.), The | 4 days 18 hours 20 minutes ago
Health care company Covidien PLC said Friday the Food and Drug Administration will take longer than expected to review the potential opioid pain drug Exalgo.
Covidien raises fiscal 2010 revenue growth outlook
Forbes | 7 days 18 hours 5 minutes ago
NEW YORK -- Drug and medical device maker Covidien PLC raised its fiscal 2010 revenue forecast Tuesday, expecting stronger sales of medical devices and pharmaceuticals.
Covidien closes $210M purchase of Aspect Medical
Boston Globe, The | 18 days 10 hours 10 minutes ago
NEW YORKDrug and medical device maker Covidien PLC said Friday it completed its $210 million purchase of Aspect Medical Systems, a company that makes brain monitoring technology.
Covidien says FDA extends review on pain drug Exalgo to Feb. 22 -- South Florida Sun-Sentinel.com
Sun-Sentinel (Fort Lauderdale, Fla.) | 4 days 18 hours 26 minutes ago
NEW YORK (AP) — Health care company Covidien PLC said Friday the Food and Drug Administration will take longer than expected to review the potential opioid pain drug Exalgo.
Covidien says it finished $210M acquisition of brain monitoring technology company Aspect
Orlando Sentinel (Fla.) | 18 days 12 hours 24 minutes ago
NEW YORK (AP) — Drug and medical device maker Covidien PLC said Friday it completed its $210 million purchase of Aspect Medical Systems , a company that makes brain monitoring technology.
Covidien gets approval for generic pain drug Actiq
Forbes | 25 days 13 hours 24 minutes ago
NEW YORK -- Covidien PLC said Friday it expects to start selling a generic version of the painkiller Actiq in early 2010.
Seven Summits Research Releases Comments on Home Depot, Salesforce.Com, Sears, Covidien and GameStop [Press Release]
PRNewswire | 8 days 13 hours 55 minutes ago
...Comments on Home Depot, Salesforce.Com, Sears, Covidien and GameStop PRNewswire CHICAGO Nov. 16 CHICAGO...Salesforce.Com Inc. , Sears Holdings Corporation , Covidien Plc and GameStop Corp. . "Our Stocks To Watch Guide...
Home Depot, Exxon Mobil, Target in focus - MarketWatch
MarketWatch | 7 days 20 hours 19 minutes ago
European shares halted their recent advances, pressured by weakness in the banking sector. Most Asian stock markets ended slightly lower, despite a strong performance for resource stocks, as fatigue set in after recent gains.
Tuesday's biggest gaining and declining stocks Movers & Shakers - MarketWatch
MarketWatch | 7 days 21 hours 57 minutes ago
Did the stock market do something even more bullish than simply go up when the S&P 500 Index closed on Monday decisively above the 1,100 level?
UPDATE 1-Covidien says FDA extends review of opiod pain drug
Reuters | 4 days 19 hours 38 minutes ago
Nov 20 (Reuters) - Covidien Plc (COV.N) said U.S. health regulators extended the review period of its experimental opioid pain drug by three months to Feb. 22, 2010.
Neuromed Receives FDA Feedback on New Drug Application for Exalgo Extended-Release Tablets [Press Release]
Business Wire | 8 days 21 hours 56 minutes ago
CombinatoRx, Incorporated (NASDAQ: CRXX) and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate EXALGOTM (hydromorphone HCl extended release) tablets, seeking FDA approval for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of...
Covidien says FDA extends Exalgo review
Kansas City Star (Mo.), The | 4 days 10 hours 15 minutes ago
Health care company Covidien PLC said Friday the Food and Drug Administration will take longer than expected to review the potential opioid pain drug Exalgo.
Critical Alerts for AT&T, Comcast, MetLife, Covidien, and Toll Brothers Released by Seven Summits Research [Press Release]
PRNewswire | 96 days 20 hours 54 minutes ago
Critical Alerts for AT&T, Comcast, MetLife, Covidien, and Toll Brothers Released by Seven Summits Research...T, Inc. , Comcast Corporation , MetLife, Inc. , Covidien plc , and Toll Brothers Inc. . In today's unsure markets...
Sign up for ANA SmartBrief
Company Overview
| Company: | Covidien plc |
|---|---|
| Industry: | Medical Devices |
| Website: | http://www.covidien.com |
No longer one of the Tyco family, Covidien is striking out on its own in the medical supplies marketplace. Its former parent spun off the unit (previously known as Tyco Healthcare) in 2007 as part of the conglomerate's much-anticipated breakup. With about $10 billion in annual sales and a product offering that includes thousands of different brands (including Mallinckrodt and Kendall), Tyco's offspring is no mewling infant. The firm supplies health care providers around the world with everything from generic pharmaceuticals and disposable medical products to diagnostic imaging contrast agents and surgical devices. Covidien has operations in nearly 60 countries.
Key Numbers
| Sales in U.S. Dollars (mil.) | 9,910 (2008) |
|---|---|
| One-year % Growth in Sales | -2.6 (2008) |
| Net Income in U.S. Dollars (mil.) | 1,361 (2008) |
| One-year % Growth in Net Income | 0.0 (2008) |
| Number of Employees | 41,700 (2008) |
| One-year % Growth in Number of Employees | -4.8 (2008) |
| Fiscal Year-End | September |